Rocmira Pérez-Nicado

SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies

Yury Valdés-Balbín, Darielys Santana-Mederos, Lauren Quintero et al. · ACS Chemical Biology · 2021 · 88 citations · Full text

Vaccination, Vaccine Development, Virus Infection +13

Biocompatible single-chain polymer nanoparticles loaded with an antigen mimetic as potential anticancer vaccine

Raquel Gracia, Marco Marradi, Gianluca Salerno et al. · ACS Macro Letters · 2018 · 56 citations · Full text

Nanoparticles, Nanotherapeutics, Engineering +24

A single dose of SARS-CoV-2 FINLAY-FR-1A vaccine enhances neutralization response in COVID-19 convalescents, with a very good safety profile: An open-label phase 1 clinical trial

Arturo Chang Monteagudo, Rolando Ochoa-Azze, Yanet Climent-Ruíz et al. · The Lancet Regional Health - Americas · 2021 · 40 citations · Full text

Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials

María Eugenia-Toledo-Romaní, Leslyhana Verdecia-Sánchez, Meiby Rodríguez-González et al. · Vaccine · 2022 · 38 citations · Full text

Vaccination, Vaccine Safety, Open Label Phase +6

A randomized, double-blind phase I clinical trial of two recombinant dimeric RBD COVID-19 vaccine candidates: Safety, reactogenicity and immunogenicity

Sonia Pérez-Rodríguez, Meiby Rodríguez-González, Rolando Ochoa-Azze et al. · Vaccine · 2022 · 31 citations · Full text

Vaccination, Vaccine Safety, Vaccine Development +7